The analyst recommends Pay Sign Inc (PYS) due to its prepaid card and payment processing services in a large addressable market. He highlights accelerating revenue growth (30% over the past year) driven by pharmacy patient affordability programs, and the company's existing profitability on a net income basis, which he views as reducing risk compared to other penny stocks.
“Revenue growth has accelerated over the past year to a 30% Pace with some Pharmacy patient affordability programs really taking off but even that at $50 million in sales is a fraction of the potential in that $700 billion market”